HLF · XBRL financial data

Herbalife financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (HLF's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	5,542	5,803	5,204	5,062	4,993	5,038
Cost of goods and services sold	1,151	1,239	1,174	1,191	1,104	1,115
Gross profit	4,391	4,564	4,031	3,871	3,889	3,923
Selling, general and administrative	2,075	2,012	1,810	1,866	1,875	—
General and administrative	—	—	—	1,701	1,726	1,664
Other operating income (expense)	15	16	15	10	6	5
Operating income (loss)	641	734	545	356	386	481
Interest expense	133	153	139	166	218	214
Other income (expense)	0	25	13	1	(11)	0
Income tax expense (benefit)	144	114	104	61	(85)	47
Net income (loss)	373	447	321	142	254	228
Earnings per share, basic USD per share	2.83	4.22	3.26	1.44	2.53	2.22
Earnings per share, diluted USD per share	2.77	4.13	3.23	1.42	2.50	2.20
Weighted average shares, basic millions of shares	132	106	99	99	101	103
Weighted average shares, diluted millions of shares	135	108	100	100	102	104

Fiscal years (HLF's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,045	602	508	575	415	353
Inventory	501	576	581	505	475	512
Prepaid and other current assets	146	188	197	238	184	188
Total current assets	1,776	1,432	1,356	1,399	1,144	1,145
Property and equipment, net	390	442	486	507	460	448
Right-of-use asset	223	220	207	186	186	168
Goodwill	101	95	93	95	88	101
Total assets	3,076	2,820	2,732	2,809	2,728	2,786
Accounts payable	89	92	90	84	70	100
Current portion of long-term debt	23	29	30	310	284	21
Total current liabilities	1,127	1,080	977	1,278	1,230	1,013
Long-term debt	2,406	2,733	2,663	2,253	1,977	1,972
Lease liability, non-current	207	201	192	168	170	156
Total liabilities	3,932	4,211	3,998	3,870	3,529	3,295
Accumulated deficit	(687)	(1,169)	(1,205)	(1,062)	(808)	(580)
Total stockholders' equity	(856)	(1,392)	(1,266)	(1,060)	(801)	(515)
Total liabilities and equity	3,076	2,820	2,732	2,809	2,728	2,786
Common shares outstanding (cover page) millions of shares	118	110	98	99	101	103

Fiscal years (HLF's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	373	447	321	142	254	228
Stock-based compensation	51	54	44	48	50	44
Net cash from operating activities	629	460	353	358	285	333
Purchases of property and equipment	112	151	156	135	122	80
Net cash from investing activities	(123)	(156)	(156)	(135)	(85)	(109)
Share repurchases	924	1,011	147	11	8	8
Net cash from financing activities	(321)	(729)	(265)	(148)	(335)	(296)
Net change in cash	207	(444)	(94)	79	(157)	(63)

SIC 5122 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (5122) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Herbalife	409	1,350	151*	104.9M	—	Q3 FY26 10-QSep 30, 2026
Nu Skin Enterprises	190	320	11*	48.7M	—	Q2 FY26 10-QJun 30, 2026
DataMeds AIadded: same SIC	2.5	1.8	(2.9)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
Cencoraadded: same SIC	2,815	84,755	2,654*	190.8M	—	Q3 FY26 10-QJun 30, 2026
Cardinal Healthadded: same SIC	4,856	year only	year only	232.6M	—	Q4 FY26 10-KJun 30, 2026
Cosmos Healthadded: same SIC	1.8	19	(1.7)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
McKessonadded: same SIC	5,164	105,380	(220)	116.6M	—	Q1 FY27 10-QJun 30, 2026
Stemtechadded: same SIC	0.2	0.6	(0.1)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
HWH Internationaladded: same SIC	1.5	0.1	0.5*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.